KR20110120481A - Natural preservative cosmetic composition containing fermented liquor of kimchi lactic acid bacteria and extract of willow bark as antibacterial ingredient - Google Patents
Natural preservative cosmetic composition containing fermented liquor of kimchi lactic acid bacteria and extract of willow bark as antibacterial ingredient Download PDFInfo
- Publication number
- KR20110120481A KR20110120481A KR1020100039910A KR20100039910A KR20110120481A KR 20110120481 A KR20110120481 A KR 20110120481A KR 1020100039910 A KR1020100039910 A KR 1020100039910A KR 20100039910 A KR20100039910 A KR 20100039910A KR 20110120481 A KR20110120481 A KR 20110120481A
- Authority
- KR
- South Korea
- Prior art keywords
- lactobacillus
- extract
- leuconostoc
- lactic acid
- acid bacteria
- Prior art date
Links
- 235000021109 kimchi Nutrition 0.000 title claims abstract description 60
- 239000000284 extract Substances 0.000 title claims abstract description 59
- 239000000203 mixture Substances 0.000 title claims abstract description 43
- 239000002537 cosmetic Substances 0.000 title claims abstract description 38
- 230000000844 anti-bacterial effect Effects 0.000 title claims abstract description 16
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 title claims description 94
- 241000894006 Bacteria Species 0.000 title claims description 61
- 235000014655 lactic acid Nutrition 0.000 title claims description 47
- 239000004310 lactic acid Substances 0.000 title claims description 47
- 241000124033 Salix Species 0.000 title claims description 34
- 239000003755 preservative agent Substances 0.000 title description 20
- 230000002335 preservative effect Effects 0.000 title description 12
- 239000004615 ingredient Substances 0.000 title description 2
- 238000000855 fermentation Methods 0.000 claims abstract description 77
- 230000004151 fermentation Effects 0.000 claims abstract description 77
- 241000186660 Lactobacillus Species 0.000 claims abstract description 30
- 229940039696 lactobacillus Drugs 0.000 claims abstract description 30
- 244000062730 Melissa officinalis Species 0.000 claims abstract description 11
- 235000010654 Melissa officinalis Nutrition 0.000 claims abstract description 11
- 229940059958 centella asiatica extract Drugs 0.000 claims abstract description 11
- 239000006210 lotion Substances 0.000 claims abstract description 8
- 239000006071 cream Substances 0.000 claims abstract description 3
- 239000000686 essence Substances 0.000 claims abstract description 3
- 239000000499 gel Substances 0.000 claims abstract description 3
- 239000002674 ointment Substances 0.000 claims abstract description 3
- 241000202221 Weissella Species 0.000 claims description 17
- 235000020221 chamomile extract Nutrition 0.000 claims description 10
- 229940119217 chamomile extract Drugs 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 8
- 241000192132 Leuconostoc Species 0.000 claims description 7
- 240000006024 Lactobacillus plantarum Species 0.000 claims description 6
- 235000013965 Lactobacillus plantarum Nutrition 0.000 claims description 6
- 229940072205 lactobacillus plantarum Drugs 0.000 claims description 6
- 241000192129 Leuconostoc lactis Species 0.000 claims description 5
- 239000002253 acid Substances 0.000 claims description 5
- 241000201465 Leuconostoc gelidum subsp. gasicomitatum Species 0.000 claims description 4
- 240000001929 Lactobacillus brevis Species 0.000 claims description 3
- 244000199885 Lactobacillus bulgaricus Species 0.000 claims description 3
- 235000013960 Lactobacillus bulgaricus Nutrition 0.000 claims description 3
- 241001647418 Lactobacillus paralimentarius Species 0.000 claims description 3
- 241000779470 Leuconostoc inhae Species 0.000 claims description 3
- 241000965142 Leuconostoc kimchii Species 0.000 claims description 3
- 241000186675 Weissella confusa Species 0.000 claims description 3
- 229940004208 lactobacillus bulgaricus Drugs 0.000 claims description 3
- 240000001046 Lactobacillus acidophilus Species 0.000 claims description 2
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 claims description 2
- 241001134659 Lactobacillus curvatus Species 0.000 claims description 2
- 241000866650 Lactobacillus paraplantarum Species 0.000 claims description 2
- 241000186612 Lactobacillus sakei Species 0.000 claims description 2
- 241001582342 Lactobacillus sakei subsp. sakei Species 0.000 claims description 2
- 241000192003 Leuconostoc carnosum Species 0.000 claims description 2
- 241001468192 Leuconostoc citreum Species 0.000 claims description 2
- 241001468194 Leuconostoc mesenteroides subsp. dextranicum Species 0.000 claims description 2
- 241001468195 Leuconostoc mesenteroides subsp. mesenteroides Species 0.000 claims description 2
- 241000412433 Weissella hanii Species 0.000 claims description 2
- 241000384856 Weissella koreensis Species 0.000 claims description 2
- 241000010758 Weissella soli Species 0.000 claims description 2
- 229940039695 lactobacillus acidophilus Drugs 0.000 claims description 2
- 150000003431 steroids Chemical class 0.000 claims description 2
- 150000007513 acids Chemical class 0.000 claims 1
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 abstract description 9
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 abstract description 6
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 abstract description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 abstract description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 abstract description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 abstract description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 abstract description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 abstract description 6
- 239000007788 liquid Substances 0.000 abstract description 5
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 abstract description 4
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 abstract description 4
- 239000008213 purified water Substances 0.000 abstract description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 4
- 235000011187 glycerol Nutrition 0.000 abstract description 3
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 abstract description 2
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 abstract description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 abstract 2
- 241000186610 Lactobacillus sp. Species 0.000 abstract 1
- 241001627205 Leuconostoc sp. Species 0.000 abstract 1
- 241000873388 Weissella sp. Species 0.000 abstract 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 abstract 1
- 125000000383 tetramethylene group Chemical group [H]C([H])([*:1])C([H])([H])C([H])([H])C([H])([H])[*:2] 0.000 abstract 1
- 230000000052 comparative effect Effects 0.000 description 88
- 241000233866 Fungi Species 0.000 description 25
- 230000000845 anti-microbial effect Effects 0.000 description 22
- 230000002421 anti-septic effect Effects 0.000 description 12
- 230000001580 bacterial effect Effects 0.000 description 11
- 238000012360 testing method Methods 0.000 description 11
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 8
- 239000002609 medium Substances 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 241000222122 Candida albicans Species 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 238000001228 spectrum Methods 0.000 description 6
- 241000588724 Escherichia coli Species 0.000 description 5
- 239000004480 active ingredient Substances 0.000 description 5
- 229940095731 candida albicans Drugs 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 5
- 241000228245 Aspergillus niger Species 0.000 description 4
- 206010015150 Erythema Diseases 0.000 description 4
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 231100000321 erythema Toxicity 0.000 description 4
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 4
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 4
- 229960002216 methylparaben Drugs 0.000 description 4
- 230000000813 microbial effect Effects 0.000 description 4
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 4
- 230000002195 synergetic effect Effects 0.000 description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 241001278079 Salix nigra Species 0.000 description 3
- 206010040880 Skin irritation Diseases 0.000 description 3
- 241000191967 Staphylococcus aureus Species 0.000 description 3
- -1 Umbelliferone Chemical compound 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 231100000475 skin irritation Toxicity 0.000 description 3
- 230000036556 skin irritation Effects 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 241000894007 species Species 0.000 description 3
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- 244000146462 Centella asiatica Species 0.000 description 2
- 235000004032 Centella asiatica Nutrition 0.000 description 2
- 240000003538 Chamaemelum nobile Species 0.000 description 2
- 235000007866 Chamaemelum nobile Nutrition 0.000 description 2
- 235000013957 Lactobacillus brevis Nutrition 0.000 description 2
- 235000007232 Matricaria chamomilla Nutrition 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 241000589516 Pseudomonas Species 0.000 description 2
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 2
- 239000004599 antimicrobial Substances 0.000 description 2
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 231100000135 cytotoxicity Toxicity 0.000 description 2
- 230000003013 cytotoxicity Effects 0.000 description 2
- 231100000263 cytotoxicity test Toxicity 0.000 description 2
- 238000001784 detoxification Methods 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 229930014626 natural product Natural products 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 230000007096 poisonous effect Effects 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 239000001965 potato dextrose agar Substances 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- GFVYDNHWTCHDSN-UHFFFAOYSA-N 14-methylpentadecyl octanoate Chemical compound CCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C GFVYDNHWTCHDSN-UHFFFAOYSA-N 0.000 description 1
- CJIJXIFQYOPWTF-UHFFFAOYSA-N 7-hydroxycoumarin Natural products O1C(=O)C=CC2=CC(O)=CC=C21 CJIJXIFQYOPWTF-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 102000044503 Antimicrobial Peptides Human genes 0.000 description 1
- 108700042778 Antimicrobial Peptides Proteins 0.000 description 1
- 241000208173 Apiaceae Species 0.000 description 1
- 241000239290 Araneae Species 0.000 description 1
- PYIXHKGTJKCVBJ-UHFFFAOYSA-N Astraciceran Natural products C1OC2=CC(O)=CC=C2CC1C1=CC(OCO2)=C2C=C1OC PYIXHKGTJKCVBJ-UHFFFAOYSA-N 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- NDVRQFZUJRMKKP-UHFFFAOYSA-N Betavulgarin Natural products O=C1C=2C(OC)=C3OCOC3=CC=2OC=C1C1=CC=CC=C1O NDVRQFZUJRMKKP-UHFFFAOYSA-N 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 244000140786 Brassica hirta Species 0.000 description 1
- 238000009631 Broth culture Methods 0.000 description 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- GXGJIOMUZAGVEH-UHFFFAOYSA-N Chamazulene Chemical compound CCC1=CC=C(C)C2=CC=C(C)C2=C1 GXGJIOMUZAGVEH-UHFFFAOYSA-N 0.000 description 1
- 240000000560 Citrus x paradisi Species 0.000 description 1
- 241000699802 Cricetulus griseus Species 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 241000380130 Ehrharta erecta Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241000134253 Lanka Species 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- 235000019493 Macadamia oil Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- MKYBYDHXWVHEJW-UHFFFAOYSA-N N-[1-oxo-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propan-2-yl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical group O=C(C(C)NC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 MKYBYDHXWVHEJW-UHFFFAOYSA-N 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- IPQKDIRUZHOIOM-UHFFFAOYSA-N Oroxin A Natural products OC1C(O)C(O)C(CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IPQKDIRUZHOIOM-UHFFFAOYSA-N 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- IHPVFYLOGNNZLA-UHFFFAOYSA-N Phytoalexin Natural products COC1=CC=CC=C1C1OC(C=C2C(OCO2)=C2OC)=C2C(=O)C1 IHPVFYLOGNNZLA-UHFFFAOYSA-N 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 244000088415 Raphanus sativus Species 0.000 description 1
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 description 1
- 240000005382 Saccharum spontaneum Species 0.000 description 1
- 241000218998 Salicaceae Species 0.000 description 1
- 240000003114 Salix fragilis Species 0.000 description 1
- 241000239226 Scorpiones Species 0.000 description 1
- 102000011842 Serrate-Jagged Proteins Human genes 0.000 description 1
- 108010036039 Serrate-Jagged Proteins Proteins 0.000 description 1
- 206010040914 Skin reaction Diseases 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 241000700647 Variola virus Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- KZNIFHPLKGYRTM-UHFFFAOYSA-N apigenin Chemical compound C1=CC(O)=CC=C1C1=CC(=O)C2=C(O)C=C(O)C=C2O1 KZNIFHPLKGYRTM-UHFFFAOYSA-N 0.000 description 1
- XADJWCRESPGUTB-UHFFFAOYSA-N apigenin Natural products C1=CC(O)=CC=C1C1=CC(=O)C2=CC(O)=C(O)C=C2O1 XADJWCRESPGUTB-UHFFFAOYSA-N 0.000 description 1
- 229940117893 apigenin Drugs 0.000 description 1
- 235000008714 apigenin Nutrition 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- IKIIZLYTISPENI-ZFORQUDYSA-N baicalin Chemical compound O1[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IKIIZLYTISPENI-ZFORQUDYSA-N 0.000 description 1
- AQHDANHUMGXSJZ-UHFFFAOYSA-N baicalin Natural products OC1C(O)C(C(O)CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 AQHDANHUMGXSJZ-UHFFFAOYSA-N 0.000 description 1
- 229960003321 baicalin Drugs 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229960001950 benzethonium chloride Drugs 0.000 description 1
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 239000003990 capacitor Substances 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 239000013592 cell lysate Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- PMRJYBALQVLLSJ-UHFFFAOYSA-N chamazulene Natural products CCC1=CC2=C(C)CCC2=CC=C1 PMRJYBALQVLLSJ-UHFFFAOYSA-N 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000013522 chelant Substances 0.000 description 1
- 238000007398 colorimetric assay Methods 0.000 description 1
- 150000004775 coumarins Chemical class 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000002784 cytotoxicity assay Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 230000003631 expected effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 235000019249 food preservative Nutrition 0.000 description 1
- 239000005452 food preservative Substances 0.000 description 1
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 208000024963 hair loss Diseases 0.000 description 1
- 230000003676 hair loss Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- UBHWBODXJBSFLH-UHFFFAOYSA-N hexadecan-1-ol;octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO.CCCCCCCCCCCCCCCCCCO UBHWBODXJBSFLH-UHFFFAOYSA-N 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 239000010469 macadamia oil Substances 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 238000010428 oil painting Methods 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000000280 phytoalexin Substances 0.000 description 1
- 150000001857 phytoalexin derivatives Chemical class 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 230000035483 skin reaction Effects 0.000 description 1
- 231100000430 skin reaction Toxicity 0.000 description 1
- 238000000527 sonication Methods 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- ORHBXUUXSCNDEV-UHFFFAOYSA-N umbelliferone Chemical compound C1=CC(=O)OC2=CC(O)=CC=C21 ORHBXUUXSCNDEV-UHFFFAOYSA-N 0.000 description 1
- HFTAFOQKODTIJY-UHFFFAOYSA-N umbelliferone Natural products Cc1cc2C=CC(=O)Oc2cc1OCC=CC(C)(C)O HFTAFOQKODTIJY-UHFFFAOYSA-N 0.000 description 1
- 229930007845 β-thujaplicin Natural products 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/524—Preservatives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Cosmetics (AREA)
Abstract
Description
본 발명은 화장료 조성물에 사용될 수 있는 천연 항균 성분, 및 이러한 항균 성분을 포함하는 화장료 조성물에 관한 것이다. 본 발명에 따른 항균 성분은 항균력이 높고 항균 스펙트럼이 광범위하다는 장점이 있으며, 화장료 성분으로 사용되기에 안전하다.The present invention relates to natural antimicrobial components that can be used in cosmetic compositions, and cosmetic compositions comprising such antimicrobial components. The antibacterial component according to the present invention has the advantage of high antibacterial activity and broad antibacterial spectrum, and is safe to be used as a cosmetic component.
천연 항균성 물질로는 알칼로이드, 플라보노이드, 피토알렉신 등의 식물 유래 항균 성분, 동물 유래의 항균 펩타이드 등이 알려져 있으며, 유기산과 지방산 등의 항균성도 알려져 있다. 이들 대부분은 산의 pH에 의한 작용과 킬레이트에 의한 효과가 주메카니즘일 것으로 추정된다.As a natural antimicrobial substance, plant-derived antimicrobial components such as alkaloids, flavonoids, phytoalexin and animal-derived antimicrobial peptides are known, and antimicrobial agents such as organic acids and fatty acids are also known. Most of them are assumed to be the main mechanism of the action of acid pH and chelate effect.
그러나, 보고된 천연 항균성 물질의 대부분은 색취, 제품 안정성 저하, 좁은 항균 스펙트럼, 제형 상의 문제점 등으로 인하여 상용화되지 못하고 있으며, 편백 추출물인 히노키티올(Hinokitiol), 황금 추출물인 바이칼린(Baicalin), 자몽 종자 추출물인 DF-100 등 극히 일부만이 상용화되고 있다.However, most of the reported natural antimicrobial substances have not been commercialized due to color odor, product stability, narrow antimicrobial spectrum, formulation problems, and the like, hinokitiol as a protein extract, Baicalin as a golden extract, and grapefruit. Only a few, such as seed extract DF-100, are commercially available.
이들 중에서 가장 제품 개발이 앞선 DF-100의 경우, 항균력은 DF-100에 포함된 유기산 및 합성보존료인 염화벤제토늄(benzethonium chloride) 때문인 것으로 알려져 있으며, 그 외 다른 천연항균제 등은 경제성이 낮거나 좁은 항균 스펙트럼 또는 물성에 의해 사용 범위가 제한되는 등의 문제가 있어, 보다 진보되고 제품화 개발이 가능한 천연 항균제가 필요한 상황이다.In the case of DF-100, the most advanced product among them, the antimicrobial activity is known to be due to the organic acid and synthetic preservative benzethonium chloride contained in the DF-100. There is a problem that the range of use is limited by the antibacterial spectrum or physical properties, there is a need for a natural antimicrobial agent that can be more advanced and commercialized development.
화장품의 품질을 장기간 유지하기 위해서는 미생물에 의한 부패를 막아주는 방부제가 필수적인데, 제품 특성상 유통기간이 길며 미생물 영양원이 많은 화장품의 경우는 더욱 그러하다.In order to maintain the quality of cosmetics for a long time, preservatives that prevent decay by microorganisms are essential, which is longer in the case of cosmetics with a long shelf life and a lot of microbial nutrients.
그러나, 기존의 방부제로서 가장 안전하고 화장품, 의약품에 널리 사용되는 파라벤 류의 방부제조차도 피부 알러지, 환경호르몬으로서의 가능성 및 내성균 유발이라는 문제가 있는 것으로 알려져 있다. 뿐만 아니라, 식품용 방부제들은 허용된 범위 내의 사용도 불신되고 있으며 지속적인 체내 축적으로 인한 급만성 독성, 돌연변이 유발 등의 새로운 문제 가능성도 대두되고 있다.However, even paraben preservatives, which are the safest as preservatives and widely used in cosmetics and medicines, are known to have problems such as skin allergies, potential as environmental hormones, and induction of resistant bacteria. In addition, food preservatives are distrusted within their acceptable range, and new problems such as acute toxicity and mutagenesis due to continuous accumulation in the body are emerging.
이러한 문제점들로 인하여 제품과 인체에 안전한 천연방부제에 대한 연구가 지속되고 있으며, 그 결과 향신료, 정유, 한약재 등과 동식물 기원의 추출물, 박테리오신 같은 미생물 기원의 천연 항균물질이 연구되고 있다.Due to these problems, research on products and natural preservatives that are safe for the human body continues, and as a result, natural antibacterial substances of microbial origin such as spices, essential oils, herbal medicines, etc.
따라서 본 발명의 목적은 기존의 화학방부제가 갖는 인체에 대한 자극 문제를 해결하고, 천연 유래로 안전성이 확보되고, 습득이 용이하고 경제적인 동시에, 기존의 천연방부제가 갖는 항균 스펙트럼이 좁다는 단점을 극복할 수 있는, 화학 방부제를 사용하지 않는 천연 방부제 화장품을 제공하고자 하는 것이다. 즉, 이러한 천연 방부제 화장품에 사용될 수 있는 천연 방부/항균 성분을 제공하는 것이다.Accordingly, an object of the present invention is to solve the problem of stimulation to the human body of a conventional chemical preservative, to secure safety from natural origin, easy to acquire and economical, and at the same time has a narrow antimicrobial spectrum of a natural preservative. It is to provide a natural preservative cosmetic that does not use chemical preservatives that can be overcome. That is, to provide a natural antiseptic / antibacterial component that can be used in such natural preservative cosmetics.
상기 본 발명의 목적을 달성하기 위하여, 본 발명은 김치유산균 발효액 및 버드나무 껍질 추출물을 항균 또는 방부 성분으로 함유하는 것을 특징으로 하는 화장료 조성물을 제공한다. 즉, 본 발명의 화장료 조성물은 방부 및 항균 성분으로 김치유산균 발효액과 버드나무 껍질 추출물을 유효성분으로 포함한다.In order to achieve the above object of the present invention, the present invention provides a cosmetic composition characterized in that it contains kimchi lactic acid bacteria fermentation broth and willow bark extract as an antibacterial or antiseptic component. That is, the cosmetic composition of the present invention contains kimchi lactic acid bacteria fermentation broth and willow bark extract as an active ingredient as an antiseptic and antibacterial component.
본 발명의 화장료 조성물은 기존의 천연방부제가 갖는 항균 스펙트럼이 좁다는 단점을 극복하고 각각의 단일 성분에 의한 항균력보다는 서로 다른 천연물 유래의 성분을 조합함으로써, 천연물질 간의 항균력 상승효과(synergy effect)를 이용한 것이다. 이와 같이 항균력을 갖는 천연물질을 조합한 결과, 기존보다 항균유효함량이 감소하고 및 항균스펙트럼이 넓어지게 되었다.The cosmetic composition of the present invention overcomes the disadvantage that the antimicrobial spectrum of the existing natural preservative is narrow and combines components derived from different natural products rather than the antimicrobial power of each single component, thereby improving the antimicrobial power synergy effect (synergy effect) between natural materials It is used. As a result of the combination of natural substances having antimicrobial activity, the antimicrobial effective content is reduced and the antimicrobial spectrum is wider than before.
본 발명에 따른 화장료 조성물에서 김치유산균 발효액과 버드나무 껍질 추출물은 각각 조성물 전체 중량에 대하여 발효액 및 추출물 각각의 건조중량으로 0.001 내지 30 중량%인 것이 바람직하다. 그 함량이 0.001 건조중량% 미만이면 기대하는 효과를 얻기 어려울 수 있으며, 30 건조중량%를 초과하면 첨가량만큼의 현저한 효과 상승이 나타나지 않을 수 있다.Kimchi lactic acid bacteria fermentation broth and willow bark extract in the cosmetic composition according to the present invention is preferably 0.001 to 30% by weight of the dry weight of each of the fermentation broth and extract relative to the total weight of the composition. If the content is less than 0.001 dry weight% it may be difficult to obtain the expected effect, if it exceeds 30 dry weight% may not show a significant effect increase by the amount added.
또한 본 발명의 화장료 조성물은 시너지 효과를 극대화하기 위하여, 바람직하게는, 김치유산균 발효액과 버드나무 껍질 추출물을 1~9:9~1의 중량비로 포함하고 있으며, 더욱 바람직하게는 3~7:7~3의 중량비로 혼합하여 포함하고 있다.In addition, the cosmetic composition of the present invention, in order to maximize the synergistic effect, preferably, containing kimchi lactic acid bacteria fermentation broth and willow bark extract in a weight ratio of 1-9: 9-1, more preferably 3-7: 7 It contains by mixing in the weight ratio of -3.
상술한 바와 같은 본 발명에 따른 김치 유산균 발효액에 있어서, 상기 김치유산균 발효액을 얻기 위해 사용되는 김치 유산균이 류코노스톡(Leuconostoc)속 김치 유산균, 락토바실루스(Lactobacillus)속 김치 유산균, 웨이셀라(Weissella)속 김치 유산균 및 이들의 혼합 유산균에서 선택되는 어느 하나일 수 있다.In the kimchi lactic acid bacterium fermentation broth according to the present invention as described above, the kimchi lactic acid bacteria used to obtain the kimchi lactic acid bacteria fermentation broth are Leuconostoc genus Kimchi lactic acid bacteria, Lactobacillus genus Kimchi lactic acid bacteria, Weissella ( Weissella ) It may be any one selected from the genus kimchi lactic acid bacteria and mixed lactic acid bacteria thereof.
상술한 바와 같은 본 발명에 따른 천연 방부제 화장료 조성물에 있어서, 상기 류코노스톡(Leuconostoc)속 김치 유산균은 류코노스톡 시트레움(Leuconostoc citreum), 류코노스톡 락티스(Leuconostoc lactis), 류코노스톡 메젠테로이드 서브스피. 덱스트라니쿰(Leuconostoc mesenteroides subsp . dextranicum), 류코노스톡 메젠테로이드 서브스피. 메젠테로이드(Leuconostoc mesenteroides subsp . Mesenteroides), 류코노스톡 아르젠티눔(Leuconostoc argentinum), 류코노스톡 카르노숨(Leuconostoc carnosum), 류코노스톡 젤리둠(Leuconostoc gellidum), 류코노스톡 김치아이(Leuconostoc kimchii), 류코노스톡 인해(Leuconostoc inhae), 류코노스톡 가시코미타툼(Leuconostoc gasicomitatum) 및 이들의 혼합 유산균으로 이루어진 군에서 선택되는 어느 하나인 것이 바람직하다.In the natural preservative cosmetic composition according to the invention as described above, the flow Pocono stock (Leuconostoc) in Kimchi lactic acid bacteria are flow Pocono stock sheet reum (Leuconostoc citreum ), Leuconostoc lactis ), leukonostock mesenteroid subspi. Dextranicum ( Leuconostoc mesenteroides subsp . dextranicum ), leukonostock mesenteroid subspi. Mezen steroid (Leuconostoc mesenteroides subsp. Mesenteroides), are Zen Ryu Kawano Stock tinum (Leuconostoc argentinum), current Kono Stock Carnot breath (Leuconostoc carnosum ), Leuconostoc gellidum ), Leuconostoc kimchii ), Leuconostoc inhae ), Leuconostoc gasicomitatum ( Leuconostoc gasicomitatum ), and any one selected from the group consisting of mixed lactic acid bacteria are preferred.
상술한 바와 같은 본 발명에 따른 천연 방부제 화장료 조성물에 있어서, 상기 락토바실루스(Lactobacillus)속 김치 유산균은 락토바실루스 브레비스(Lactobacillus brevis), 락토바실루스 애시도필루스(Lactobacillus acidophilus), 락토바실루스 불가리커스(Lactobacillus bulgaricus), 락토바실루스 플란타룸(Lactobacillus plantarum), 락토바실루스 김치아이(Lactobacillus kimchii), 락토바실루스 파라플란타룸(Lactobacillus paraplantarum), 락토바실루스 쿠르바투스 서브시피. 쿠르바투스(Lactobacillus curvatus subsp . curvatus), 락토바실루스 사케이 서브시피. 사케이(Lactobacillus sakei subsp . sakei) 및 이들의 혼합 유산균으로 이루어진 군에서 선택되는 어느 하나인 것이 바람직하다.In the natural preservative cosmetic composition according to the present invention as described above, the Lactobacillus ( Lactobacillus ) kimchi lactobacillus is Lactobacillus brevis ( Lactobacillus brevis ), Lactobacillus ashophilus ( Lactobacillus acidophilus ), Lactobacillus Bulgari (Lactobacillus) bulgaricus), Lactobacillus plantarum ), Lactobacillus kimchii , Lactobacillus paraplantarum , Lactobacillus curbatus subsiphy. Lactobacillus curvatus subsp . curvatus ), Lactobacillus sakei subsidiary . Lactobacillus sakei subsp . sakei ) and mixed lactic acid bacteria thereof are preferably any one selected from the group consisting of.
상술한 바와 같은 본 발명에 따른 천연 방부제 화장료 조성물에 있어서, 상기 웨이셀라(Weissella)속 김치 유산균이 웨이셀라 코레엔시스(Weissella koreensi), 웨이셀라 하니아이(Weissella hanii), 웨이셀라 김치아이(Weissella kimchii), 웨이셀라 솔리(Weissella soli), 웨이셀라 콘푸사(Weissella confusa) 및 이들의 혼합 유산균으로 이루어진 군에서 선택되는 어느 하나인 것이 바람직하다.In the natural preservative cosmetic composition according to the present invention as described above, the Weissella genus Kimchi lactic acid bacteria is Wesselella Corensis ( Weissella) koreensi ), Weissella hanii ), Weissella ( Weissella) kimchii ), Weissella soli ), Weissella Confusa confusa ) and their mixed lactic acid bacteria are preferably any one selected from the group consisting of.
상기 발효액은 본 발명에 따른 김치유산균을 적합한 액체 배지에서 배양한 배양액 자체, 상기 배양액을 여과 또는 원심분리하여 균주를 제거한 여액(여과액 또는 원심분리한 상등액), 상기 배양액을 초음파 처리하거나 상기 배양액에 용해효소(lysozyme)를 처리하여 수득한 세포 파쇄액 등을 포함하나 이에 한정되는 것은 아니다.The fermentation broth is culture medium itself cultured kimchi lactic acid bacteria according to the present invention in a suitable liquid medium, filtrate (filtered or centrifuged supernatant) from which the strain was removed by filtration or centrifugation, the culture solution by sonication or to the culture medium Cell lysates obtained by treating lysozyme, but are not limited thereto.
한편 본 발명에 따른 버드나무 껍질 추출물에 있어 버드나무는 버드나무과(Salicaceae) 버드나무속(Salix)에 속하는 관목 및 교목으로서 대부분 북온대지방이 원산지이다. 버드나무는 낙엽교목으로서 10-15㎝ 정도에 달하며, 가지는 아래로 처지고, 소가지는 갈색 또는 적갈색이다. 잎은 날카로운 톱니형이며, 끝이 길고 뾰족하고, 꽃은 3-4월에 피며 열매가 맺는 시기는 5월이다. 잎을 유엽(柳葉), 꽃을 유화(柳花), 과실을 유실(柳實), 속 질긴 껍질을 유백피(柳白皮)라 하여 약용한다. 중국 원산으로, 전남, 경기, 및 중국과 유럽의 들판에서 자란다. 큰 버드나무로는 살릭스 니그라(S. nigra), 살릭스 프라길리스(S. fragilis), 살릭스 알바(S. alba) 등 3종이 있는데 모두 키가 20㎝ 이상 자란다. 살릭스 니그라는 북아메리카에서 자라며, 나머지 둘은 유라시아가 원산지이지만 지금은 귀화식물로 널리 퍼져 자라고 있다.On the other hand, in the willow bark extract according to the present invention willow is a shrub and tree belonging to the willow (Salicaceae) willow (Salix), most of the northern temperate zone is native. Willow is a deciduous arbor tree, about 10-15㎝ long, with its branches drooping and its branches are brown or reddish brown. Leaves are sharp serrate, long and pointed, flowers bloom in March-April, and fruiting season is May. The leaves are oily leaves, the flowers are oil painting, the fruits are lost, and the inner skin is medicated with milky skin. Native to China, it grows in Jeonnam, Gyeonggi, and fields of China and Europe. There are three large willow trees: S. nigra, S. fragilis, and S. alba, all taller than 20 cm. Salix Nigra grows in North America, and the other two are native to Eurasia, but are now widespread as naturalized plants.
본 발명에 따른 버드나무 껍질 추출물은 예를 들어 다음과 같이 제조될 수 있으나, 이러한 방법에 본 발명의 권리범위가 한정되는 것은 아니며 본 발명이 속한 분야에서 통상적인 지식을 가진 자에게 알려진 다른 방법들도 사용될 수 있다. Willow bark extract according to the present invention may be prepared as follows, for example, but the scope of the present invention is not limited to this method and other methods known to those skilled in the art to which the present invention pertains. May also be used.
시판되는 버드나무 껍질(S. Nigra Bark)를 구입하여 분쇄한 분쇄물을 정제수; 메탄올, 에탄올, 프로필알코올, 부틸알코올 등의 탄소수 1-4의 저급 알코올; 글리세린, 부틸렌글라이콜, 프로필렌글라이콜 등의 다가 알코올; 메틸아세테이트, 에틸아세테이트, 아세톤, 벤젠, 헥산, 디에틸에테르, 디클로로메탄 등의 탄화수소계 용매; 또는 이들은 혼합 용매에 넣고, 냉각콘덴서가 달린 환류 추출기에서 일정 시간 끓이거나, 가열하여 추출한 다음, 여과한 후 잔사를 같은 방법으로 일정 횟수 더 추출한다. 각각의 추출액을 합하여 상온에서 여과하여 불용성 물질을 제거한 후, 냉각 콘덴서가 달린 증류장치에서 60℃로 감압농축한 후 동결건조하면 건조 추출물을 얻을 수 있다. 이외에 상당 시간 동안 실온에서 침적시켜 유효성분을 추출할 수도 있다.Purified water obtained from commercially available willow bark (S. Nigra Bark); Lower alcohols having 1 to 4 carbon atoms such as methanol, ethanol, propyl alcohol, and butyl alcohol; Polyhydric alcohols such as glycerin, butylene glycol, and propylene glycol; Hydrocarbon solvents such as methyl acetate, ethyl acetate, acetone, benzene, hexane, diethyl ether and dichloromethane; Or they are put in a mixed solvent, boiled in a reflux extractor with a cooling capacitor for a certain time, or extracted by heating, then filtered and the residue is extracted a number of times in the same manner. Each extract was combined and filtered at room temperature to remove insoluble matters, and then concentrated under reduced pressure at 60 ° C. in a distillation apparatus equipped with a cooling condenser and then lyophilized to obtain a dry extract. In addition, the active ingredient can be extracted by immersion at room temperature for a considerable time.
또한, 본 발명의 화장료 조성물은 화장수, 에센스, 로션, 크림, 젤, 연고 또는 피부세정제 등의 제형으로 제형화될 수 있다.In addition, the cosmetic composition of the present invention may be formulated in a formulation such as lotion, essence, lotion, cream, gel, ointment or skin cleaner.
본 발명은 또한 김치유산균 발효액과 버드나무 껍질 추출물의 시너지 효과 이외에 본 발명의 조성물에 카모마일 추출물, 센텔라아시아티카 추출물 및 레몬밤 추출물로 이루어지는 군으로부터 선택되는 하나 이상이 추가로 포함될 경우 그 효과가 더욱더 시너지적으로 향상된다는 놀라운 발견에 기초한다.In addition to the synergistic effect of kimchi lactic acid bacteria fermentation broth and willow bark extract, the effect is even more effective when one or more selected from the group consisting of chamomile extract, centella asiatica extract and lemon balm extract is further included in the composition of the present invention. It is based on the surprising discovery of synergistic improvements.
상기 카모마일은 아피제닌(apigenin)과 그 유도체, 루틴(rutin) 등의 플라보노이드류와 움벨리페론(Umbelliferone)등의 쿠마린류 화합물, 카마줄렌(chamazulene) 등의 휘발성 오일을 함유하고 있으며 항염, 통증 완화, 상처 치유 작용이 있어 피부나 점막의 염증을 완화하는데 효과가 있다. 센텔라아시아티카는 마다가스카르 섬 및 인도, 스리랑카 등의 지역에서는 예로부터 나병치료 및 피부병 치료제로 널리 쓰여왔고 또한 이 지역에서는 위장병에 이 약초를 달여서 먹어왔다. 미나리과(Umbelliferae)에 속하며 한국에서는 병풀 또는 호랑이 풀이라고 불리우며 세계적으로 분포하고 한국에는 제주도 일부 해안에서 주로 자생하는 다년초이다. 이 식물 추출물의 주요 기능은 피부조직재생 등으로 의약품인 복합치료제의 주원료로 사용되고 있다. 레몬밤은 레몬과 유사한 향이 있으며, 이 향은 감정을 편안하게 진정시켜 주며 심장 박동수를 낮추고 혈압을 낮춘다. 전갈이나 독거미에 물렸을 때 해독작용이 있고 설사를 완화시키며 바이러스를 막는 데 큰 효과가 있다. 천연두에도 효능이 있고 치통이 있을 때 입가심용으로 사용해 왔다. 독버섯 해독, 복통, 위궤양, 생리통 억제, 생리 촉진에 사용해 왔으며 예로부터 방향요법에 필수적으로 사용해 왔다. 잎과 가지에서 추출한 기름은 탈모방지, 목욕제 등으로 이용되며 차는 진정, 건위, 강장, 신경 고양 등에 효능이 있으며, 기분을 상쾌하게 하기 위하여도 마신다. 상기 카모마일 추출물, 센텔라아시아티카 추출물 및 레몬밤 추출물은 각각 카모마일, 센텔라 아시아티카, 레몬밤으로부터 추출한 추출물로서, 통상 공지된 추출방법에 따라 추출물을 수득할 수 있으며, 시판되는 것을 구입하여 사용할 수도 있다. 추출용매의 종류 및 함량 등도 목적에 따라 임의 선정하여 사용할 수 있다. 각각 조성물 전체 중량에 대하여 추출물의 건조 중량으로 0.001 내지 30 중량%을 사용할 수 있다.The chamomile contains apigenin and its derivatives, flavonoids such as rutin, coumarin compounds such as Umbelliferone, and volatile oils such as chamazulene, and anti-inflammatory and pain relief. It has a healing effect on the skin and mucous membranes. Centella asiatica has been widely used as a treatment for leprosy and skin diseases in the Madagascar Islands, India and Sri Lanka. It belongs to the Umbelliferae and is called perennial or tiger grass in Korea. It is distributed throughout the world, and in Korea, it is a perennial plant that grows mainly on some coasts of Jeju Island. The main function of this plant extract is to regenerate skin tissue, and is used as a main ingredient of complex therapeutics. Lemon balm has a lemon-like scent that calms your emotions, lowers your heart rate and lowers blood pressure. When bitten by scorpions or poisonous spiders, they have detoxification, relieve diarrhea and have a great effect on the virus. It is also effective for smallpox and has been used for nausea when you have toothache. It has been used for poisonous mushroom detoxification, abdominal pain, gastric ulcers, suppressing menstrual cramps, and promoting menstruation. The oil extracted from the leaves and branches is used to prevent hair loss, bath, etc. Tea is effective for soothing, healthing, tonic, and nerve uplifting. The chamomile extract, centella asiatica extract and lemon balm extract are extracts from chamomile, centella asiatica and lemon balm, respectively, to obtain an extract according to a known extraction method, and may be used by purchasing a commercially available one. have. The type and content of the extraction solvent may also be arbitrarily selected according to the purpose. 0.001 to 30% by weight of the dry weight of the extract, based on the total weight of the composition, respectively.
본 발명은 김치유산균 발효액 또는 버드나무 껍질 추출물의 항균 효과를 확인하였을 뿐만 아니라, 김치유산균 발효액 또는 버드나무 껍질 추출물을 단독으로 사용하였을 때보다는 혼합하였을 때 방부력이 시너지적으로 상승하는 것을 확인할 수 있었다. 또한 김치유산균 발효액과 버드나무 껍질 추출물은 피부에 매우 안전하여, 이들을 유효성분으로 포함하는 화장료 조성물의 사용이 가능할 뿐만 아니라, 이러한 화장료 조성물은 우수한 항균 효과를 나타내고, 기존의 화학 방부제를 대체할 수 있는 수준의 방부 효과를 갖는다. 따라서, 이들 천연물 유래의 항균 효과가 있는 성분을 화장료 조성물에 첨가함으로써 우수한 항균 효과를 갖는 천연방부제 화장료 조성물을 얻을 수 있다.The present invention not only confirmed the antimicrobial effect of Kimchi Lactobacillus fermentation broth or willow bark extract, but also showed synergistic increase in antiseptic force when mixed with Kimchi Lactobacillus fermentation broth or Willow bark extract. . In addition, kimchi lactic acid bacterium fermentation broth and willow bark extract is very safe for the skin, and it is possible to use a cosmetic composition containing them as an active ingredient, and these cosmetic compositions exhibit excellent antimicrobial effects and can replace conventional chemical preservatives. Has a level of antiseptic effect. Therefore, the natural preservative cosmetic composition which has the outstanding antibacterial effect can be obtained by adding the component which has an antimicrobial effect derived from these natural products to a cosmetic composition.
이하, 본 발명의 이해를 돕기 위하여 실시예 등을 들어 상세하게 설명하기로 한다. 그러나, 본 발명에 따른 실시예들은 여러 가지 다른 형태로 변형될 수 있으며, 본 발명의 범위가 하기 실시예들에 한정되는 것으로 해석되어서는 안 된다. 본 발명의 실시예들은 당업계에서 평균적인 지식을 가진 자에게 본 발명을 보다 완전하게 설명하기 위해 제공되는 것이다.
Hereinafter, examples and the like will be described in detail to help understand the present invention. However, the embodiments according to the present invention can be modified into various other forms, and the scope of the present invention should not be construed as being limited to the following embodiments. Embodiments of the present invention are provided to more fully describe the present invention to those skilled in the art.
<김치유산균 발효액의 제조><Production of Kimchi Lactic Acid Bacteria Fermentation Solution>
하기 표 1과 같은 김치유산균을 이용하여 배양액을 제조하였는데 그 과정은 다음과 같다. 김치유산균을 일정한 농도(약 105∼107 cells/mL)로 무(radish)를 포함하는 MRS(Difco) broth 배양액에 접종한 후 30℃에서 5일 동안 배양하였다. 1차로 상기 배양액을 기공 크기 0.2 ㎛인 여과막(membrane filter)을 이용하여 여과한 후 여과액을 진공(×12.5)으로 농축하였으며, 다시 2차로 상기 배양액을 기공 크기 0.2 ㎛인 여과막(membrane filter)을 이용하여 여과하여 최종 김치유산균 발효액을 얻었다. 이때의 건조중량은 약 20 w/w%(3g, 105℃, 3hrs)이었다. 또한, 김치유산균 발효액은 시판되는 제품을 구입하여 사용할 수도 있다.To prepare a culture using kimchi lactic acid bacteria as shown in Table 1, the process is as follows. Kimchi lactic acid bacteria were inoculated in MRS (Difco) broth culture containing radish at a constant concentration (about 10 5-10 7 cells / mL) and then incubated at 30 ° C. for 5 days. First, the culture solution was filtered using a membrane filter having a pore size of 0.2 μm, and the filtrate was concentrated in vacuo (× 12.5). Secondly, the culture medium was filtered with a membrane having a pore size of 0.2 μm. Filtration was carried out to obtain a final kimchi lactic acid bacteria fermentation broth. The dry weight at this time About 20 w / w% (3 g, 105 ° C., 3 hrs). In addition, kimchi lactic acid bacteria fermentation broth can be purchased and used commercially available products.
<버드나무 껍질 추출물의 제조><Preparation of Willow Bark Extract>
시판되는 버드나무 껍질(S. Nigra Bark)을 구입하여 분쇄한 분쇄물 100g을 용매 정제수 3L에 넣고, 냉각콘덴서가 달린 환류 추출기에서 3시간 끓여 추출한 다음, 100메쉬 여과포로 여과한 후 잔사를 같은 방법으로 1회 더 추출한다. 각각의 추출액을 합하여 상온에서 화트만(Whatman) 2번 여과지로 여과하여 불용성 물질을 제거한 후, 냉각 콘덴서가 달린 증류장치에서 60℃로 감압농축한 후 동결건조하면 건조 추출물을 얻었으며, 이후의 실험에서 사용하였다.
Purified willow bark ( S. Nigra Bark) was added to 100 g of pulverized pulverized powder in 3 L of solvent purified water, boiled for 3 hours in a reflux extractor with a cooling condenser, filtered through 100 mesh filter cloth, and the residue was subjected to the same method. Extract one more time. Each extract was combined and filtered using Whatman No. 2 filter paper at room temperature to remove insoluble matters, and then concentrated under reduced pressure at 60 ° C. in a distillation apparatus equipped with a cooling condenser and then lyophilized to obtain a dry extract. Used in
<실험예 1> 세포 독성 시험Experimental Example 1 Cytotoxicity Test
화장품에 사용되는 원료로서의 1차 안정성을 검증하고자 위에서 제조한 김치유산균 발효액 과 버드나무 껍질 추출물에 대하여 V79-세포(차이니스 햄스터, 폐조직 섬유아세포의 연속 세포주)를 배양하여 MTT 시험을 하는 방법[Mossman T. (1983). Rapid Colorimetric Assay for Cellular Growth & Survival: application to proliferation & cytotoxicity assays. Journal of Immunological Methods 65, 55-63]을 수행하여 세포독성을 평가하였으며, 그 결과를 하기 표 2에 나타내었다.Method of MTT test by culturing V79-cells (Chinese hamster, continuous cell line of lung tissue fibroblasts) to Kimchi Lactobacillus fermentation broth and willow bark extract prepared above to verify primary stability as a raw material used in cosmetics [ Mossman T. (1983). Rapid Colorimetric Assay for Cellular Growth & Survival: application to proliferation & cytotoxicity assays. Journal of Immunological Methods 65, 55-63] was performed to evaluate the cytotoxicity, the results are shown in Table 2 below.
aIC50: 억제농도(Inhibitory Concentration) 50, 50%의 세포를 사멸시키는 농도. a IC 50 : Inhibitory Concentration 50, a concentration that kills 50% of cells.
상기 표 2에서 보는 바와 같이, 본 발명의 김치유산균 발효액(8종) 및 버드나무 껍질 추출물의 IC50 값이 소디움라우릴설페이트에 비하여 높으므로 소디움라우릴설페이트보다 세포독성이 낮은 것을 알 수 있고, 따라서 인체에 안전함을 알 수 있다.
As shown in Table 2, the IC 50 value of the kimchi lactic acid bacteria fermentation broth (8 species) and willow bark extract of the present invention is higher than sodium lauryl sulfate, it can be seen that the cytotoxicity is lower than sodium lauryl sulfate, Therefore, it can be seen that it is safe for the human body.
<실험예 2> 인체에 대한 1차 자극성 시험(폐쇄 첩포)Experimental Example 2 Primary Irritant Test on Human Body (Closed Patch)
김치유산균 발효액 및 버드나무 껍질 추출물을 함유한 시료의 안전성을 알아보기 위하여, 하기와 같이 인체 첩포 시험(human patch test)을 통하여 인체에 대한 1 차 자극시험을 시행하였다.In order to determine the safety of the sample containing the kimchi lactic acid bacteria fermentation broth and willow bark extract, a primary stimulation test was performed on the human body through the human patch test as follows.
건강한 성인 남녀 20명을 대상으로 CTFA 가이드라인(The Cosmetic, Toiletry and Fragrance Association. Inc. Washington, D.C., 20036, 1991)에 따라 실시하였다. 핀 쳄버(Finn Chamber)에 시료 및 용액 15 ㎎/15 ㎕를 적하시킨 후, 이것을 시험 부위인 인체의 팔에 얹어 테이프로 고정시켰다. 이어서, 24시간 동안 첩포한 다음 첩포를 제거하고, 다시 2시간 경과한 후 시험 부위의 피부 반응을 다음 기준에 따라 판정하였다. 다음 표 3은 판정 기준을 나타내고, 표 4는 각 시료의 피부 자극 지수를 나타낸다.Twenty healthy men and women were tested according to CTFA guidelines (The Cosmetic, Toiletry and Fragrance Association. Inc. Washington, D.C., 20036, 1991). 15 mg / 15 μl of the sample and solution were added dropwise to a Fin chamber, and it was placed on the arm of the human body as a test site and fixed with tape. Subsequently, the patch was removed for 24 hours, then the patch was removed, and after 2 hours, the skin reaction at the test site was determined according to the following criteria. Table 3 below shows the criteria for determination, and Table 4 shows the skin irritation index of each sample.
피부 자극 지수=[∑(점수×자극의 수)]/전체 시험자수×총 자극 평가 횟수Skin irritation index = [∑ (score × number of stimuli)] / total number of test subjects × total stimulus evaluations
상기 표 4에서 보는 바와 같이, 본 발명에 따른 화장료 조성물의 유효성분인 김치유산균 발효액(8종)과 버드나무 껍질 추출물은 피부에 안전한 성분임을 알 수 있다.
As shown in Table 4, it can be seen that kimchi lactic acid bacteria fermentation broth (8 species) and willow bark extract, which are the active ingredients of the cosmetic composition according to the present invention, are safe ingredients for the skin.
<실험예 3> 항균력 평가Experimental Example 3 Evaluation of Antimicrobial Activity
김치유산균 발효액, 버드나무 껍질 추출물, 카모마일 추출물, 센텔라아시아티카 추출물 및 레몬밤 추출물에 대하여 세균 3종과 진균 2종에 대한 항균력을 평가하였다. 실험에 사용한 미생물 균주는 스타필로코커스 아우레우스(Staphylococcus aureus), 에스케리치아 콜리(Escherichia coli), 슈도모나스 아에루기노사(Paeudomonas aeruginosa), 캔디다 알비칸스(Candida albicans) 및 아스퍼질러스 나이거(Aspergillus niger)였다. 스타필로코커스 아우레우스(Staphylococcus aureus), 에스케리치아 콜리(Escherichia coli) 및 슈도모나스 아에루기노사(Paeudomonas aeruginosa)는 세균용 고체 배지(Brain Heart Infusion Agar)에서 37 ℃, 24시간 전배양하고 이를 105~6 CFU/㎖ 농도가 되도록 희석하여 접종 균액으로 준비하였다. 캔디다 알비칸스(Candida albicans)는 곰팡이용 고체 배지(Potato Dextrose Agar)에서 30 ℃, 48시간 전배양하여 105~6 CFU/㎖의 접종액을 준비하였다. 아스퍼질러스 나이거(Aspergillus niger)는 곰팡이용 고체 배지로 만든 사면배지(Potado Dextrose Slant media)에 접종하여 30 ℃, 48시간 전 배양하여 105~6 CFU/㎖의 농도로 균액을 제조하였다. 세균은 Brain Heart Infusion Broth를, 진균은 Potato Dextrose Broth를 액체 배지로 사용하였다.Kimchi Lactobacillus fermentation broth, willow bark extract, chamomile extract, Centella asiatica extract and lemon balm extract were evaluated for antibacterial activity against three bacteria and two fungi. The microbial strain used in the experiment was Staphylococcus aureus ), Escherichia coli), Pseudomonas rugi Ah Labor (Paeudomonas aeruginosa ), Candida albicans and Aspergillus niger . Staphylococcus aureus ), Escherichia coli ) and Pseudomonas aeruginosa were precultured in bacterial solid medium (Brain Heart Infusion Agar) at 37 ° C. for 24 hours and diluted to a concentration of 10 5-6 CFU / mL to prepare inoculation bacteria. . Candida albicans ( Candida albicans ) was incubated in a solid medium for mold (Potato Dextrose Agar) at 30 ℃, 48 hours to prepare 10 5 ~ 6 CFU / ㎖ inoculum. Aspergillus niger (Apergillus niger ) was inoculated in a medium (Potado Dextrose Slant media) made of a solid medium for the fungus was incubated at 30 ℃, 48 hours ago to prepare a bacterial solution at a concentration of 10 5 ~ 6 CFU / ㎖. Bacteria were Brain Heart Infusion Broth and fungi were Potato Dextrose Broth as liquid medium.
위와 같이 제조하여 멸균한 액체 배지를 96 웰 U 자형 마이크로 플레이트의 각 웰에 100 ㎕씩 넣고, 김치유산균 발효액, 버드나무 껍질 추출물, 카모마일 추출물, 센텔라아시아티카 추출물 및 레몬밤 추출물을 96 웰 U 자형 마이크로 플레이트의 첫 번째와 두 번째 웰에 각각 100 ㎕씩 넣은 후, 두 번째 웰부터 1:1 계단 희석하였다. 그 다음 각 웰에 들어 있는 시료 희석액에 균을 접종한 후 세균은 37 ℃ 배양기에서 24시간, 진균은 30 ℃ 배양기에서 48시간 배양하였다. 배양 후 Alamar Blue를 주입한 후 육안으로 청색에서 분홍색으로의 색 변화가 일어나지 않은 시료의 가장 낮은 농도를 균에 대한 항균 물질의 최소 성장 억제 농도 (Minimal Inhibitory Concentration, MIC)로 결정하였다. 다음 표 5는 결정된 각 성분의 최소 성장 억제 농도(MIC)를 나타낸 것이다.100 μl each of the prepared and sterilized liquid medium in each well of a 96 well U-shaped microplate, and the kimchi lactobacillus fermentation broth, willow bark extract, chamomile extract, Centella asiatica extract and lemon balm extract were 96 well U-shaped 100 μl each was added to the first and second wells of the microplate, and then diluted 1: 1 steps from the second well. Then, after inoculating the bacteria in the sample diluent in each well, bacteria were incubated for 24 hours in a 37 ℃ incubator, fungi were incubated for 48 hours in a 30 ℃ incubator. After incubation, Alamar Blue was injected and the lowest concentration of the sample that did not change color from blue to pink was determined as the minimum inhibitory concentration (MIC) of the antimicrobial material against the bacteria. Table 5 below shows the minimum growth inhibitory concentration (MIC) of each component determined.
1번 균: 스타필로코커스 아우레우스(Staphylococcus aureus) Fungus 1: Staphylococcus aureus )
2번 균: 에스케리치아 콜리(Escherichia coli) Fungus 2: Escherichia coli )
3번 균: 슈도모나스 아에루기노사(Paeudomonas aeruginosa) Germ 3: Paeudomonas Pseudomonas aeruginosa aeruginosa )
4번 균: 캔디다 알비칸스(Candida albicans)No. 4 strains: Candida albicans (Candida albicans )
5번 균: 아스퍼질러스 나이거(Aspergillus niger)Fungus 5: Aspergillus niger )
상기 표 5에서 보는 바와 같이, 김치유산균 발효액(8종)은 세균에 대한 항균력이 메틸파라벤 보다 우수하였고, 버드나무 껍질 추출물은 특히 진균에 대한 항균력이 우수하였으며, 이들 모두 메틸파라벤과 동등한 수준의 우수한 항균력을 나타내었다. 카모마일 추출물, 센텔라아시아티카 추출물 또는 레몬밤 추출물의 경우는 항균력이 나타났으나 항균성능이 김치유산균 발효액이나 버드나무 껍질 추출물에 비해서 떨어졌다.
As shown in Table 5, the kimchi lactic acid bacteria fermentation broth (8 species) was superior to methyl paraben antibacterial activity, willow bark extract was particularly excellent antibacterial activity against fungi, all of which are equivalent to methyl paraben It showed antibacterial activity. Chamomile extract, Centella asiatica extract or lemon balm extract showed antimicrobial activity, but the antimicrobial activity was lower than that of Kimchi lactic acid bacteria fermentation broth or willow bark extract.
<실험예 4> 챌린지(Challenge) 테스트, 방부력 및 방부력 상승 효과 평가Experimental Example 4 Challenge Test, Evaluation of Antiseptic and Antiseptic Effects
하기 조성 및 표 6에 제시된 혼합비에 따라 실시예 1-4 및 비교예 1-5의 조성물들을 각각 제조하였다. 실시예에서 김치유산균 발효액은 각 1종의 김치유산균만으로 제조한 발효액을 사용하였다. 각 실시예 및 비교예에서 사용된 균주의 경우 발효액 샘플 1의 경우 표 7, 발효액 샘플 2의 경우 표 8, 발효액 샘플 3의 경우 표 9, 발효액 샘플 4의 경우 표 10, 발효액 샘플 5의 경우 표 11, 발효액 샘플 6의 경우 표 12, 발효액 샘플 7의 경우 표 13, 발효액 샘플 8의 경우 표 14에 나타내었다.The compositions of Examples 1-4 and Comparative Examples 1-5 were prepared according to the following compositions and mixing ratios shown in Table 6, respectively. In the example, the kimchi lactic acid bacteria fermentation broth was prepared using only one kimchi lactic acid bacteria. For the strains used in each Example and Comparative Example Table 7 for fermentation broth sample 1 Table 7, fermentation broth sample 2 Table 8, fermentation broth sample 3 Table 9, fermentation broth sample 4 Table 10, fermentation broth sample 5 11, Table 12 for fermentation broth sample 6, Table 13 for fermentation broth sample 7 and Table 14 for fermentation broth sample 8.
다음 처방에 따라 통상의 로션 제조방법에 의해 로션을 제조하였다. 세토스테아릴알코올 0.8 중량(w/w)%, 자기유화형 모노스테아린산 1.0 중량(w/w)%, 밀납 0.5 중량(w/w)%, 스테아린산 0.5 중량(w/w)%, 유동 파라핀 8.0 중량(w/w)%, 스쿠알란 4.0 중량(w/w)%, 마카데미아 오일 2.0 중량(w/w)%, 이소세틸옥타노에이트 2.0 중량(w/w)%, 디메틸실록산 0.3 중량(w/w)%, 모노스테아린산 소르비탄 0.5 중량(w/w)%, 모노스테아린산 폴리에틸렌글리콜 1.2 중량(w/w)%, 글리세린 4.0 중량(w/w)%, 프로필렌글리콜 4.0 중량(w/w)%, 베타인 4.0 중량(w/w)%, 카르복시폴리머 0.12 중량(w/w)%, 트리에탄올아민 0.15 중량(w/w)%, 향료 적량 및 색소 적량을 사용하였고, 방부제 또는 유효성분을 하기 표 6에 표시된 중량(w/w) 만큼 첨가하였으며, 정제수를 가하여 100 중량(w/w)%로 조정하였다.The lotion was prepared by a conventional lotion preparation method according to the following prescription. Cetostearyl alcohol 0.8 wt% (w / w)%, self-emulsifying monostearic acid 1.0 wt% (w / w)%, beeswax 0.5 wt% (w / w)%, stearic acid 0.5 wt% (w / w)%, liquid paraffin 8.0 Weight (w / w)%, squalane 4.0 weight (w / w)%, macadamia oil 2.0 weight (w / w)%, isocetyloctanoate 2.0 weight (w / w)%, dimethylsiloxane 0.3 weight ( w / w)%, monostearic acid sorbitan 0.5 weight (w / w)%, monostearic acid polyethylene glycol 1.2 weight (w / w)%, glycerin 4.0 weight (w / w)%, propylene glycol 4.0 weight (w / w )%, Betaine 4.0 weight (w / w)%, carboxypolymer 0.12 weight (w / w)%, triethanolamine 0.15 weight (w / w)%, fragrance amount and pigment amount were used, preservatives or active ingredients It was added by the weight (w / w) shown in Table 6, and was adjusted to 100 weight (w / w)% by adding purified water.
제조된 실시예 1-4의 각 조성물에 대하여 다음과 같은 챌린지 테스트 를 통해서 김치유산균 발효액과 버드나무 껍질 추출물 혼합사용으로 인한 방부력 상승효과 평가 및 상기 혼합 사용에 카모마일 추출물, 센텔라 아시아티카 추출물 또는 레몬밤 추출물 첨가에 의한 방부력 상승효과 평가를 하였다.Evaluation of antiseptic effect due to the mixed use of kimchi lactic acid bacteria fermentation broth and willow bark extract through the following challenge test for each composition of Example 1-4 prepared chamomile extract, Centella asiatica extract or The antiseptic effect was evaluated by adding lemon balm extract.
챌린지(Challenge) 테스트에 사용한 미생물 균주는 세균으로 스타필로코커스 아우레우스(Staphylococcus aureus), 에스케리치아 콜리(Escherichia coli), 및 슈도모나스 아에루기노사(Paeudomonas aeruginosa) 3가지 혼합 균주를 사용하였고, 진균으로 캔디다 알비칸스(Candida albicans) 및 아스퍼질러스 나이거(Aspergillus niger)의 2가지 혼합 균주를 사용하였으며, CTFA의 가이드라인(CTFA Microbiology Guideline) 시험법을 사용하였다.The microbial strain used in the Challenge test is a bacterium, Staphylococcus. aureus), Escherichia coli (Escherichia coli), Pseudomonas and rugi Ah Labor (Paeudomonas aeruginosa) were used three mixed culture, the fungi Candida albicans (Candida two mixed strains of albicans ) and Aspergillus niger were used, and CTFA Microbiology Guideline assay was used.
항균력 평가와 동일한 방법으로 균을 전배양하여, 세균은 제품 1 g 당 1.6×106 개가 되도록 접종하고, 진균은 4×105 개가 되도록 접종한 후 1~28일까지 시간 경과 관찰을 하였다. 다음 표 7-14는 각각 실시예 1-4 및 비교예 1-5에서 제조한 제품에서 시간 경과에 따른 균수 변화를 나타낸 것이고 각 표에 따라 사용된 김치유산균이 다르다.The bacteria were precultured in the same manner as the antimicrobial evaluation, and bacteria were inoculated to 1.6 × 10 6 per g of product, and the fungi were inoculated to be 4 × 10 5 and observed for 1 to 28 days. The following Table 7-14 shows bacterial count changes over time in the products prepared in Examples 1-4 and Comparative Examples 1-5, respectively, and the kimchi lactic acid bacteria used were different according to each table.
상기 표 7은 발효액 샘플 1의 결과이다.Table 7 shows the results of fermentation broth sample 1.
상기 표 8은 발효액 샘플 2의 결과이다.Table 8 shows the results of fermentation broth sample 2.
상기 표 9는 발효액 샘플 3의 결과이다.Table 9 shows the results of fermentation broth sample 3.
상기 표 10은 발효액 샘플 4의 결과이다.Table 10 shows the results of fermentation broth sample 4.
상기 표 11은 발효액 샘플 5의 결과이다.Table 11 shows the results of fermentation broth sample 5.
상기 표 12는 발효액 샘플 6의 결과이다.Table 12 shows the results of fermentation broth sample 6.
상기 표 13은 발효액 샘플 7의 결과이다.Table 13 shows the results of fermentation broth sample 7.
상기 표 14는 발효액 샘플 8의 결과이다.Table 14 shows the results of fermentation broth sample 8.
상기 표 7 내지 14에서 보는 바와 같이, 김치유산균 발효액 또는 버드나무 껍질 추출물을 함유한 화장료는 기존 화학 방부제를 사용한 화장료와 동등 수준의 방부력을 발휘하는 것을 알 수 있다. 또한 김치유산균 발효액 및 버드나무 껍질 추출물 모두 함유하는 실시예 1에서 제조한 화장료는 동일함량에서 김치유산균 발효액 또는 버드나무 껍질 추출물을 단일성분으로 하는 것보다 방부성능이 향상됨을 확인할 수 있다. 카모마일 추출물, 센텔라아시아티카 추출물 또는 레몬밤 추출물 등을 본 발명에 의한 김치유산균 발효액 및 버드나무 껍질 추출물 혼합물과 함께 혼합하는 경우 실시예 2, 3 및 4에서 확인할 수 있듯이 방부성능이 더욱 향상됨을 확인할 수 있다.As shown in Tables 7 to 14, it can be seen that the cosmetic containing kimchi lactic acid bacteria fermentation broth or willow bark extract exhibits the same level of antiseptic power as cosmetics using conventional chemical preservatives. In addition, the cosmetic preparation prepared in Example 1 containing both the kimchi lactic acid bacteria fermentation broth and willow bark extract can be confirmed that the antiseptic performance is improved than the kimchi lactic acid bacteria fermentation broth or willow bark extract as a single component. When the chamomile extract, Centella asiatica extract or lemon balm extract and the like are mixed with the Kimchi lactic acid bacteria fermentation broth and willow bark extract mixture according to the present invention, it can be seen that the antiseptic performance is further improved. Can be.
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020100039910A KR20110120481A (en) | 2010-04-29 | 2010-04-29 | Natural preservative cosmetic composition containing fermented liquor of kimchi lactic acid bacteria and extract of willow bark as antibacterial ingredient |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020100039910A KR20110120481A (en) | 2010-04-29 | 2010-04-29 | Natural preservative cosmetic composition containing fermented liquor of kimchi lactic acid bacteria and extract of willow bark as antibacterial ingredient |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20110120481A true KR20110120481A (en) | 2011-11-04 |
Family
ID=45391594
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020100039910A KR20110120481A (en) | 2010-04-29 | 2010-04-29 | Natural preservative cosmetic composition containing fermented liquor of kimchi lactic acid bacteria and extract of willow bark as antibacterial ingredient |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20110120481A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101966184B1 (en) * | 2018-09-21 | 2019-04-05 | 주식회사 제이투케이바이오 | NTI-FUNGAL Cosmetic Composition of Malassezia furfur |
US20200368146A1 (en) * | 2019-05-22 | 2020-11-26 | Mary Ahern | Method of cosmetic preservation |
KR102262466B1 (en) * | 2020-12-04 | 2021-06-10 | 한국콜마 주식회사 | Preservative system comprising lactobacillus acidophilus ferment and antispetic |
-
2010
- 2010-04-29 KR KR1020100039910A patent/KR20110120481A/en not_active Application Discontinuation
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101966184B1 (en) * | 2018-09-21 | 2019-04-05 | 주식회사 제이투케이바이오 | NTI-FUNGAL Cosmetic Composition of Malassezia furfur |
US20200368146A1 (en) * | 2019-05-22 | 2020-11-26 | Mary Ahern | Method of cosmetic preservation |
EP3972618A4 (en) * | 2019-05-22 | 2023-10-18 | Ahern, Mary | Method of cosmetic preservation |
KR102262466B1 (en) * | 2020-12-04 | 2021-06-10 | 한국콜마 주식회사 | Preservative system comprising lactobacillus acidophilus ferment and antispetic |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101532005B1 (en) | Natural preservative comprising citrus junos seed extract and manufacturing method thereof | |
KR101525976B1 (en) | Natural preservative composition containing Agrimonia Pilosa Extract, Coptis Chinensis Root Extract and Green Tea Extract | |
KR100986249B1 (en) | Natural antimicrobial and antiseptic substance made from Dryopteris crassirhizoma root extract complex | |
KR101806800B1 (en) | Complex natural preservative comprising scutellaria baicalensis extract and method manufacture the same | |
KR101824687B1 (en) | Antimicrobial composition comprising natural plant extract | |
KR101511747B1 (en) | Natural Preservative Composition Containing the Extract of Lisimachiae Herba, Galla Rhois, Cassia Bark and Caryophylli Flos | |
KR101465696B1 (en) | Antibacterial and insect resistance composition | |
KR20130128888A (en) | Natural preservative composition containing the extract of nelumbo nucifera leaf, flower, seed and root | |
KR102448555B1 (en) | Antimicrobial and Antifungal Cosmetic Composition Containing Complex Extract of Chamaecyparis obtusa, Rosa rugosa, and Melissa officinalis as Active Ingredient | |
KR101473925B1 (en) | Antiseptic compositions comprising Magnolia grandiflora extract and cosmetic compositions containing the same | |
KR20110120481A (en) | Natural preservative cosmetic composition containing fermented liquor of kimchi lactic acid bacteria and extract of willow bark as antibacterial ingredient | |
KR102163969B1 (en) | Cosmetic Compositions Containing Fermented Extracts of Vernicia fordii | |
KR101839612B1 (en) | Natural Preservative Composition Containing Plant Extract Complex as Active Ingredient | |
KR100981407B1 (en) | The cosmetic composition containing the natural antibiotic-complex consisted of the nelumbo nucifera leaf extracts, Kochia scoparia extracts and Lycium chinense extracts | |
KR101598194B1 (en) | Multifunctional deodorant cosmetic composition for hair and body | |
KR20190102364A (en) | Anti-aging composition and cosmetic using the same | |
KR102180666B1 (en) | Cosmetic Composition for Skin Care Containing Fermented Extracts of Applemint, Citron and Sparassis Crispa | |
KR20180103374A (en) | A cosmetic composition containing Dendropanax morbifera ferment extract as an active ingredient and Functional cosmetics having anti-inflammation and sensitive skin improvement containing the same | |
KR101507533B1 (en) | Natural preservative composition containing Silver Needle White Tea Extract, Magnolia Obovata Bark Extract and Terminalia Chebula Bark Extract | |
KR20070080707A (en) | Natural antiseptic substance from japanese honeysuckle and cosmetic composition containing it | |
KR20140127525A (en) | Compositions for enhancing skin barrier and reducing skin stimulus comprising mixture extract of Hibiscus mutabilis L. and Patrinia villosa Juss. | |
KR102074129B1 (en) | Antiseptic composition comprising the extract from bark of Melia azedarach L. var. japonica Makino, Paeonia lactiflora Pall. and Zanthoxylum piperitum DC and a cosmetic composition comprising the same | |
KR20180031119A (en) | Natural antimicrobial composition and cosmetic composition containing the same | |
KR101776202B1 (en) | Natural preservative compositionpreservative composition and manufacturing method thereof | |
KR100787634B1 (en) | Cosmetic composition having antiseptic activity |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |